Evidence map›Paper›PMID 37112908›Full record

Observational studyViruses2023

Longitudinal Detection of Twenty DNA and RNA Viruses in Allogeneic Hematopoietic Stem Cell Transplant Recipients Plasma.

Marie-Céline Zanella, Diem-Lan Vu, Krisztina Hosszu-Fellous, Dionysios Neofytos, Chistian Van Delden, Lara Turin, Antoine Poncet, Federico Simonetta, Stavroula Masouridi-Levrat, Yves Chalandon and 2 more

Open access · goldAbstract readObservational Study
In one paragraph

Observational study in Viruses, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed, 1 pooled it
2.3field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 1 synthesis or guideline pooled it, 10 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 2 institutions in 1 country.

Marie-Céline ZanellaDivision of Infectious Diseases, Geneva University Hospitals, 1211 Geneva, Switzerland.ORCID 0000-0001-9544-1295
Diem-Lan VuDivision of Infectious Diseases, Geneva University Hospitals, 1211 Geneva, Switzerland.
Krisztina Hosszu-FellousDivision of Infectious Diseases, Geneva University Hospitals, 1211 Geneva, Switzerland.
Dionysios NeofytosDivision of Infectious Diseases, Geneva University Hospitals, 1211 Geneva, Switzerland.ORCID 0000-0001-6970-2869
Chistian Van DeldenDivision of Infectious Diseases, Geneva University Hospitals, 1211 Geneva, Switzerland.
Lara TurinLaboratory of Virology, Division of Laboratory Medicine, Geneva University Hospitals, 1211 Geneva, Switzerland.
Antoine PoncetCenter for Clinical Research, Department of Health and Community Medicine, University of Geneva, 1206 Geneva, Switzerland.
Federico SimonettaFaculty of Medicine, University of Geneva Medical School, 1206 Geneva, Switzerland.
Stavroula Masouridi-LevratFaculty of Medicine, University of Geneva Medical School, 1206 Geneva, Switzerland.
Yves ChalandonFaculty of Medicine, University of Geneva Medical School, 1206 Geneva, Switzerland.ORCID 0000-0001-9341-8104
Samuel CordeyDivision of Infectious Diseases, Geneva University Hospitals, 1211 Geneva, Switzerland.ORCID 0000-0002-2684-5680
Laurent KaiserDivision of Infectious Diseases, Geneva University Hospitals, 1211 Geneva, Switzerland.
University of Geneva · CHUniversity Hospital of Geneva · CH

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Metagenomics revealed novel and routinely overlooked viruses, representing sources of unrecognized infections after allogeneic hematopoietic stem cell transplantation (allo-HSCT). We aim to describe DNA and RNA virus prevalence and kinetics in allo-HSCT recipients' plasma for one year post HSCT. We included 109 adult patients with first allo-HSCT from 1 March 2017 to 31 January 2019 in this observational cohort study. Seventeen DNA and three RNA viral species were screened with qualitative and/or quantitative r(RT)-PCR assays using plasma samples collected at 0, 1, 3, 6, and 12 months post HSCT. TTV infected 97% of patients, followed by HPgV-1 (prevalence: 26-36%). TTV (median 3.29 × 10

Indexed as

Hematopoietic Stem Cell TransplantationMerkel cell polyomavirusRNA VirusesTorque teno virusVirus DiseasesAdultDNA, ViralHumansTransplant RecipientsDNA, Viralanellovirusbloodhuman pegivirusPCRpolyomavirustransplantationTTVviromevirus

Identifiers

PMID37112908
PMCPMC10142697
OpenAlexW4363675000

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.